Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-16

Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Participants With Non-Alcoholic Steatohepatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating BFKB8488A vs placebo in non-alcoholic steatohepatitis was terminated with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BFKB8488A

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-alcoholic Steatohepatitis | Phase 2 | Status: TERMINATED | Results posted: 2024-04-16